Variation in psychosis gene ZNF804A is associated with a refined schizotypy phenotype but not neurocognitive performance in a large young male population

Schizophrenia Bulletin

Volumn 39, Issue 6, 2013, Pages 1252-1260

  Stefanis, Nicholas C ^a,b,c,e   Hatzimanolis, Alex ^b,d   Avramopoulos, Dimitrios ^d   Smyrnis, Nikolaos ^a,b   Evdokimidis, Ioannis ^a   Stefanis, Costas N ^a   Weinberger, Daniel R ^d   Straub, Richard E ^d  

^a UNIVERSITY MENTAL HEALTH RESEARCH INSTITUTE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Aberrant salience; Paranoia; Psychosis; Schizophrenia; Schizotypy; ZNF804A

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL RECORD REVIEW; PARANOIA; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIZOPHRENIA; TRAINING; WORKING MEMORY; ZNF804A GENE;

ABERRANT SALIENCE; PARANOIA; PSYCHOSIS; SCHIZOPHRENIA; SCHIZOTYPY; ZNF804A;

ADOLESCENT; ADULT; COGNITION DISORDERS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GREECE; HAPLOTYPES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; PARANOID DISORDERS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SCHIZOTYPAL PERSONALITY DISORDER; YOUNG ADULT;

EID: 84885967387     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs110     Document Type: Article

References (44)

1. O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40:1053-1055.
2. Cummings E, Donohoe G, McDonald C, et al. Clinical symptomatology and the psychosis risk gene ZNF804A. Schizophr Res. 2010;122:273-275.
3. Hill MJ, Bray NJ. Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A. Mol Psychiatry. 2011;16:787-789.
4. Steinberg S, Mors O, Borglum AD, et al.; Genetic Risk and Outcome in Psychosis. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry. 2011;16:59-66.
5. Schanze D, Ekici AB, Gawlik M, Pfuhlmann B, Reis A, Stöber G. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population. Am J Med Genet B Neuropsychiatr Genet. 2011;156: 198-203.
6. Williams HJ, Norton N, Dwyer S, et al.; Molecular Genetics of Schizophrenia Collaboration (MGS) International Schizophrenia Consortium (ISC), SGENE-plus, GROUP. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry. 2011;16:429-441.
7. Riley B, Thiselton D, Maher BS, et al. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry. 2010;15:29-37.
8. Zhang F, Chen Q, Ye T, et al. Evidence of sex-modulated association of ZNF804A with schizophrenia. Biol Psychiatry. 2011;69:914-917.
9. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636-645. (Pubitemid 41079594)
10. Esslinger C, Walter H, Kirsch P, et al. Neural mechanisms of a genome-wide supported psychosis variant. Science. 2009;324:605.
11. Paulus FM, Krach S, Bedenbender J, et al. Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity [published online ahead of print October 31, 2011]. Hum Brain Mapp. doi:10.1002/hbm.21434.
12. Rasetti R, Sambataro F, Chen Q, Callicott JH, Mattay VS, Weinberger DR. Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry. 2011;68:1207-1217.
13. Walter H, Schnell K, Erk S, et al. Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry. 2011;16:462-470.
14. Walters JT, Corvin A, Owen MJ, et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry. 2010;67:692-700.
15. Donohoe G, Rose E, Frodl T, et al. ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia. Neuroimage. 2011;54:2132-2137.
16. Cousijn H, Rijpkema M, Harteveld A, et al. Schizophrenia risk gene ZNF804A does not influence macroscopic brain structure: an MRI study in 892 volunteers [published online ahead of print January 24, 2012]. Mol Psychiatry. doi:10.1038/mp.2011.181.
17. Kelleher I, Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med. 2011;41:1-6.
18. Stefanis NC, Trikalinos TA, Avramopoulos D, et al. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry. 2007;62:784-792. (Pubitemid 47374644)
19. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. 1991;17:555-564.
20. Stefanis NC, Smyrnis N, Avramopoulos D, Evdokimidis I, Ntzoufras I, Stefanis CN. Factorial composition of self-rated schizotypal traits among young males undergoing military training. Schizophr Bull. 2004;30:335-350. (Pubitemid 38828540)
21. Stefanis N, Vitoratou S, Ntzoufras I, Smyrnis N, Evdokimidis I, Stefanis C. Psychometric properties of the Greek version of the Schizotypal Personality Questionnaire (SPQ) in young male obligatory conscripts: a two years test-retest study. Pers Individ Dif. 2006;41:1275-1286. (Pubitemid 44348541)
22. Chapman LJ, Chapman JP, Raulin ML. Body-image aberration in schizophrenia. J Abnorm Psychol. 1978;87:399-407. (Pubitemid 9010146)
23. Stefanis NC, Hanssen M, Smirnis NK, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002;32:347-358. (Pubitemid 34162592)
24. Derogatis R. Symptom Checklist-90-R (SCL-90-R). Minneapolis, MN: Computer Systems; 1993.
25. Stefanis NC, Henquet C, Avramopoulos D, et al. COMT Val158Met moderation of stress-induced psychosis. Psychol Med. 2007;37:1651-1656. (Pubitemid 47606851)
26. Compton MT, Goulding SM, Bakeman R, McClure-Tone EB. Confirmation of a four-factor structure of the Schizotypal Personality Questionnaire among undergraduate students. Schizophr Res. 2009;111:46-52.
27. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992;49:624-629.
28. Dominguez MD, Wichers M, Lieb R, Wittchen HU, van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull. 2011;37:84-93.
29. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988;26:223-238.
30. Smyrnis N, Avramopoulos D, Evdokimidis I, Stefanis CN, Tsekou H, Stefanis NC. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men. Biol Psychiatry. 2007;61:845-853. (Pubitemid 46412273)
31. Avramopoulos D, Stefanis NC, Hantoumi I, Smyrnis N, Evdokimidis I, Stefanis CN. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry. 2002;7:706-711. (Pubitemid 34984947)
32. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575. (Pubitemid 47330214)
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc. 1995;57:289-300.
34. Lenzenweger MF. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy: an update. Schizophr Bull. 1994;20:121-135. (Pubitemid 24071097)
35. Yasuda Y, Hashimoto R, Ohi K, et al. Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene. Neurosci Lett. 2011;495: 216-220.
36. Hargreaves A, Morris DW, Rose E, et al. ZNF804A and social cognition in patients with schizophrenia and healthy controls. Mol Psychiatry. 2012;17:118-119.
37. Kety SS, Wender PH, Jacobsen B, et al. Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. Arch Gen Psychiatry. 1994;51:442-455. (Pubitemid 24180491)
38. Yaralian PS, Raine A, Lencz T, et al. Elevated levels of cognitive-perceptual deficits in individuals with a family history of schizophrenia spectrum disorders. Schizophr Res. 2000;46:57-63.
39. Vollema MG, Sitskoorn MM, Appels MC, Kahn RS. Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr Res. 2002;54:39-45. (Pubitemid 34164517)
40. Kremen WS, Faraone SV, Toomey R, Seidman LJ, Tsuang MT. Sex differences in self-reported schizotypal traits in relatives of schizophrenic probands. Schizophr Res. 1998;34:27-37. (Pubitemid 28518169)
41. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet. 2007;80:531-538.
42. Clarke GM, Cardon LR. Aspects of observing and claiming allele flips in association studies. Genet Epidemiol. 2010;34:266-274.
43. Auerbach BD, Osterweil EK, Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature. 2011;480:63-68.
44. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13-23. (Pubitemid 36042420)